Imaging of HER2 with [89Zr]pertuzumab in response to T-DM1 therapy

Authors

Adriana V.F. Massicano, University of Alabama, Birmingham
Supum Lee, Yale University
Bryant K. Crenshaw, University of Alabama, Birmingham
Tolulope A. Aweda, University of Alabama, Birmingham
Retta El Sayed, University of Alabama, Birmingham
Ian Super, University of Alabama, Birmingham
Ron Bose, Washington University School of Medicine in St. Louis
Bernadette V. Marquez-Nostra, Yale University
Suzanne E. Lapi, University of Alabama, Birmingham

Journal

Cancer Biotherapy & Radiopharmaceuticals

Publication Date

2019

Volume

34

Issue

4

Inclusive Pages

209-217

Document Type

Open Access Publication

DOI

10.1089/cbr.2018.2654

Rights and Permissions

This is a copy of an article published in Cancer Biotherapy & Radiopharmaceuticals © 2019 © Mary Ann Liebert, Inc.; Cancer Biotherapy & Radiopharmaceuticals is available online at: http://online.liebertpub.com.

Recommended Citation

Massicano, Adriana V.F.; Lee, Supum; Crenshaw, Bryant K.; Aweda, Tolulope A.; El Sayed, Retta; Super, Ian; Bose, Ron; Marquez-Nostra, Bernadette V.; and Lapi, Suzanne E., "Imaging of HER2 with [89Zr]pertuzumab in response to T-DM1 therapy." Cancer Biotherapy & Radiopharmaceuticals. 34, 4. 209-217. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7742